Association of time-to-treatment with prognosis in pneumocystis pneumonia among immunocompromised patients without HIV infection: a multi-center, retrospective observational cohort study
Abstract Background Pneumocystis jirovecii pneumonia (PCP) in non-human immunodeficiency virus (HIV) patients is associated with high morbidity and mortality. Although prior studies have linked delayed treatment to worse outcomes, they are often limited by small sample sizes and inadequate adjustmen...
Saved in:
| Main Authors: | Haruka Fujioka, Hiroki Matsui, Yuya Homma, Tatsuya Nagai, Ayumu Otsuki, Hiroyuki Ito, Shinichiro Ohmura, Toshiaki Miyamoto, Daisuke Shichi, Watari Tomohisa, Yoshihito Otsuka, Kei Nakashima |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Infectious Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-025-10933-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selective expression of Pneumocystis antigens in different patients during a suspected outbreak of Pneumocystis pneumonia
by: Caroline S. Meier, et al.
Published: (2025-05-01) -
Pneumocystis jirovecii pneumonia in AIDS and non-AIDS immunocompromised patients – an update
by: Yuan-Ti Lee, et al.
Published: (2018-10-01) -
Progress of researches on the differential diagnosis of Pneumocystis jiroveci infection and colonization
by: LI Xingchen, TONG Jin
Published: (2025-01-01) -
Clinical characteristics of Pneumocystis jirovecii pneumonia in hemodialysis patients
by: Na Young Kim, et al.
Published: (2025-04-01) -
Pneumocystis jirovecii in Respiratory Tract of Immunocompromised Patients: A Study in a Tertiary Care Center in Bangalore, South India
by: Pratibha Shamanna1*, et al.
Published: (2024-03-01)